JosephLeoKelleyMD
Obstetrics & Gynecology • Pittsburgh, PAGynecologic Oncology
Professor of Obstetrics & Gynecology, University Pittsburgh
Dr. Kelley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Halket St
Suite 0610
Pittsburgh, PA 15213Phone+1 412-641-5411
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1989 - 1991
UPMC Medical EducationResidency, Obstetrics and Gynecology, 1985 - 1989
Saint Louis University School of MedicineClass of 1985
Certifications & Licensure
PA State Medical License 1986 - 2024
TX State Medical License 1990 - 2010- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer Start of enrollment: 2008 Dec 01
- Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- Association of neighborhood social vulnerability with ovarian cancer survival.Lauren Borho, Esther Elishaev, Riyue Bao, Emily O'Brien, Kaitlyn Dinkins
Gynecologic Oncology. 2024-11-21 - Association of allostatic load with overall survival in epithelial ovarian cancer.Lauren Borho, Riyue Bao, Esther Elishaev, Kaitlyn D Dinkins, Emily E O'Brien
Gynecologic Oncology. 2024-07-01 - 1 citationsRegional Control and Chemoradiotherapy Dose Response for Clinically Involved Lymph Nodes in Patients with Locally Advanced Endometrial Cancers Who are Not Candidates f...Uzoma K. Iheagwara, John A. Vargo, Michelle M. Boisen, Sarah Taylor, J.L. Berger
Clinical Oncology. 2021-03-01
Journal Articles
- Proposal for a Risk-Based Categorization of Uterine CarcinosarcomaFrederick R Ueland, Esther Elishaev, Tanja Pejovic, Todd B Sheridan, Terry Morgan, Joseph L Kelley, Malcolm S Ross, Stephen H Bush, Ardeshir Hakam, Lynda D Roman, Meri..., Annals of Surgical Oncology
- Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine CarcinosarcomaLynda D Roman, Terry Morgan, Joseph L Kelley, Todd B Sheridan, Stephen H Bush, Merieme M Klobocista, Miriam D Post, Malcolm S Ross, Frederick R Ueland, Ardeshir Hakam,..., Annals of Surgical Oncology
- Survival Advantage Associated with Multimodal Therapy in Women with Node‐Positive (Stage‐IIIC) Uterine Papillary Serous Carcinoma: A National Cancer Database StudyJ F Lin, K Muniz, P Gehrig, R P Edwards, A B Olawaiye, S Beriwal, P Sukumvanich, J L Kelley, BJOG: An International Journal of Obstetrics & Gynaecology
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
